{"id":"namfp","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"NaMFP inhibits monocarboxylate transporters (MCTs), which are responsible for the cellular uptake and efflux of lactate, pyruvate, and other monocarboxylates. By blocking these transporters, the drug alters cellular metabolism and lactate homeostasis, which may have therapeutic effects in conditions where lactate accumulation or metabolism plays a pathogenic role.","oneSentence":"NaMFP is a sodium-dependent monocarboxylate transporter inhibitor that reduces cellular uptake of lactate and other monocarboxylates.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:56:36.777Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06140745","phase":"NA","title":"Evaluation of Dentifrice Formulations to Remineralize Enamel and Dentine Subsurface Lesions in a Double-Blind In-Situ Clinical Trial","status":"COMPLETED","sponsor":"Procter and Gamble","startDate":"2020-10-05","conditions":"Caries","enrollment":10},{"nctId":"NCT02740803","phase":"NA","title":"Total Salivary Fluoride Concentration of Healthy Adult Subjects Following Toothbrushing With Different Formulations of Fluoridated Toothpastes With and Without Post-brushing Water Rinsing.","status":"COMPLETED","sponsor":"University of Leeds","startDate":"2016-04","conditions":"Caries","enrollment":120},{"nctId":"NCT01827670","phase":"PHASE3","title":"Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-02","conditions":"Dentine Hypersensitivity","enrollment":119},{"nctId":"NCT01128946","phase":"PHASE4","title":"Enamel Remineralization Potential of Dentifrices in Situ","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-11","conditions":"Dental Caries","enrollment":83},{"nctId":"NCT00708097","phase":"PHASE3","title":"In Situ Caries Efficacy of Fluoride Toothpastes","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-04","conditions":"Caries","enrollment":57},{"nctId":"NCT00708305","phase":"PHASE3","title":"Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-06","conditions":"Dental Caries","enrollment":65},{"nctId":"NCT00708123","phase":"PHASE3","title":"In Situ Caries of Fluoride Toothpastes","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-11","conditions":"Healthy Subjects, Partial Denture Wearers, Caries","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":26,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"NaMFP","genericName":"NaMFP","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}